Ninti Hospital is building a need-driven, specialty-led healthcare network — anchored in operational single-super-specialty cardiac centres in tier-2/3 Bihar, extending to multi-specialty hospitals in Patna and Lucknow, and culminating in a flagship onco-focused super-specialty hospital in Delhi NCR.
Ninti Hospital is a healthcare network under construction — combining operational single-super-specialty cardiac centres, multi-specialty hospitals under build-out, and a proposed flagship onco-focused super-specialty hospital in Delhi NCR. The network is designed to address India's acute healthcare infrastructure gap: with bed density at 1.42 per 1,000 vs the WHO benchmark of 3.0, and doctor density at 0.86 vs 1.0.
Ninti's current footprint includes Saharsa Cardiac Care (50 beds, operational, broke even September 2024), Muzaffarpur Cardiac Care (broke even September 2024), and Patna Mother Care (100 beds, infrastructure ready). The expansion roadmap adds Purnea (100 beds, 2026), Patna Multispecialty (200 beds, 2027), Lucknow Multispecialty (200 beds, 2027), and the flagship Delhi NCR Onco-focused Super-Specialty Hospital (350 beds, 2029) — taking network capacity to approximately 1,000 beds.
The Delhi NCR project is the pitch: a INR 219 Crore project positioned to capture the Indian oncology market (projected INR 2.5 trillion by 2027) with Delhi NCR cancer incidence rising 23% by 2026. The financial model projects EBITDA breakeven in Year 3, first positive PAT in Year 4, and 30% PAT margin by Year 10 on INR 1,334 Cr of revenue.
| INR Cr | Y1 | Y2 | Y3 | Y4 | Y5 | Y7 | Y10 |
|---|---|---|---|---|---|---|---|
| Revenue | 145 | 313 | 468 | 649 | 809 | 1,064 | 1,334 |
| Gross Contribution | 68 | 160 | 243 | 344 | 437 | 596 | 800 |
| Gross Margin | 47% | 51% | 52% | 53% | 54% | 56% | 60% |
| EBITDA | (33) | 25 | 87 | 175 | 255 | 387 | 553 |
| EBITDA Margin | -23% | 8% | 19% | 27% | 32% | 36% | 41% |
| PAT | (84) | (19) | 49 | 112 | 167 | 268 | 394 |
| PAT Margin | -58% | -6% | 10% | 17% | 21% | 25% | 30% |
Flagship onco-focused super-specialty hospital in Delhi NCR — 350 beds, 30-month construction, COD Month 31. Full oncology suite: surgical, medical, radiation, gynae; BMT; IGRT; PET-CT. 99.93% debt-funded (INR 218.85 Cr @ 6%). Projected Y4 first positive PAT (INR 112 Cr), Y10 revenue INR 1,334 Cr at 41% EBITDA · 30% PAT margin · INR 1,961 Cr closing cash. Cardiac-centre breakeven proof points already validated in Bihar.